Find Clinical Trials

Study Title: A Prospective, Open-label, Phase 4 Study to Evaluate the Safety of Pembrolizumab (KEYTRUDA®) in Subjects with Unresectable or Metastatic Melanoma or PD-L1 positive Non-small Cell Lung Cancer (NSCLC) in India.
  • Doctor Dr. Sewanti Limaye
  • Project No MK-3475-593
  • CTRI No CTRI/2018/12/016591

    For more details please click on link

Study Title: A Phase III, Randomized, Multicenter, Double-blind, Placebo-controlled Study to Determine the Efficacy of Adjuvant Durvalumab in Combination with Platinum-based Chemotherapy in Completely Resected Stage II-III NSCLC (MeRmaiD-1)
  • Doctor Dr. Sewanti Limaye
  • Project No D910LC00001
  • CTRI No CTRI/2020/09/027739

    For more details please click on link

Study Title: A Prospective, Multicentre, Phase-IV Clinical Trial of Olaparib in Indian Patients with Platinum Sensitive Relapsed Ovarian Cancer who are in Complete or Partial Response Following Platinum Based Chemotherapy and Metastatic Breast Cancer with Germline BRCA1/2 Mutation (SOLI Study).
  • Doctor Dr. Sewanti Limaye
  • Project No D0816R00025
  • CTRI No CTRI/2020/03/024196

    For more details please click on link

Study Title: A Phase III, Double-blind, Placebo-controlled, Multi-centre International Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients with Resectable Stages II and III Non-small Cell Lung Cancer (AEGEAN)
  • Doctor Dr. Sewanti Limaye
  • Project No D9106C00001
  • CTRI No CTRI/2019/06/019634

    For more details please click on link

Study Title: A Phase 4 Study of Nivolumabin Combination with Ipilimumab in Patients with Previously Untreated Advanced Renal Cell Carcinoma and Intermediate-or Poor-risk Factors Conducted in India.
  • Doctor Dr. Sewanti Limaye
  • Project No CA209-7C9
  • CTRI No CTRI/2020/10/028626

    For more details please click on link

Study Title: A Phase 2 Basket Study of the Oral TRK Inhibitor Larotrectinib in Subjects With NTRK Fusion-positive Tumors.
  • Doctor Dr. Sewanti Limaye
  • Project No 20289
  • CTRI No CTRI/2021/07/034739

    For more details please click on link

Study Title: A phase 2 multicenter, randomized, double-blind, placebo-controlled study to assess the safety and efficacy of ifetroban in patients with diffuse cutaneous systemic sclerosis or systemic sclerosis-associated pulmonary arterial hypertension.
  • Doctor Dr. Sunilkumar Singh
  • Project No CPI-IFE-004
  • CTRI No CTRI/2019/04/018679

    For more details please click on link

Study Title: A Prospective, Multicentre, Non- Interventional Real-World, and Data Collection Registry to Evaluate the Effectiveness, Safety and Durability of SUPERA Stent for the Treatment of De Novo or Restenosis Superficial Femoral Artery or Complex Femoropopliteal Artery Lesions in Indian patients.
  • Doctor Dr. Vimal Someshwar
  • CTRI No CTRI/2019/09/021451

    For more details please click on link

Study Title: EPIK-B3: A Phase III, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of alpelisib (BYL719) in combination with nab-paclitaxel in patients with advanced triple negative breast cancer with either phosphoinositide-3-kinase catalytic subunit alpha (PIK3CA) mutation or phosphatase and tensin homolog protein (PTEN) loss without PIK3CA mutation.
  • Doctor Dr. Sewanti Limaye
  • Project No CBYL719H12301
  • CTRI No CTRI/2020/09/027887

    For more details please click on link

Study Title: A prospective, 16 week, phase IV study to evaluate safety, tolerability and effectiveness in patients with severe dementia of the Alzheimer’s type exposed to rivastigmine (Exelon) 15 cm2 transdermal patch
  • Doctor Dr. Annu Aggarwal
  • Project No CENA713DIN01
  • CTRI No CTRI/2018/02/011948

    For more details please click on link

Study Title: A Multi-centre Phase II, Double-Blind, Randomised Study of Savolitinib in Combination with Osimertinib vs Savolitinib in Combination with Placebo in Patients with EGFRm PLUS and MET Amplified Locally Advanced or Metastatic Non-Small Cell Lung Cancer who have Progressed Following Treatment with Osimertinib.
  • Doctor Dr. Sewanti Limaye
  • Project No D5084C00009
  • CTRI No CTRI/2020/12/029451

    For more details please click on link

Study Title: A Phase III, Randomized, Multicenter, Parallel-Group, Double-Blind, Double-Dummy Study in Adolescent and Adult Female Participants Comparing the Efficacy and Safety of Gepotidacin to Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infection (Acute Cystitis).
  • Doctor Dr. Sanjay Pandey
  • Project No 204989
  • CTRI No CTRI/2020/01/022715

    For more details please click on link

Study Title: A prospective, multicentre and open label clinical study to evaluate safety and performance of CREDENCE™ BtK Sirolimus Eluting BioResorbable Peripheral Scaffold System in subjects with Critical Limb Ischemia following Percutaneous Transluminal Angioplasty of below the knee arteries.
  • Doctor Dr. Vimal Someshwar
  • Project No CREDENCE™ BtK
  • CTRI No CTRI/2016/11/007473

    For more details please click on link

Study Title: A prospective, open label and multicentric clinical study to evaluate safety and performance of CREDENCE™ BRS Sirolimus Eluting BioResorbable Peripheral Scaffold System in subjects with de novo native peripheral artery lesions. .
  • Doctor Dr. Vimal Someshwar
  • Project No CREDENCE™ BRS – 1
  • CTRI No CTRI/2017/01/007638

    For more details please click on link